Danaher to Acquire Masimo in Transaction Valued at $9.9 Billion
Masimo will become a standalone operating company within Danaher’s diagnostics segment, adding its pulse oximetry and patient monitoring technologies to the portfolio.
Read More
Author: SR Edit Staff
ProSomnus Secures $38 Million Strategic Investment to Scale Smart Sleep Medicine
The funding will support the development of remote patient monitoring tools, proprietary sleep diagnostic devices, and comparative clinical studies.
Read More
Japan Grants Orphan Drug Designation to Eisai’s Novel Orexin Agonist for Narcolepsy
E2086, a selective orexin 2 receptor agonist, aims to address the pathophysiology of narcolepsy by activating orexinergic neurons.
Read More
Inspire Medical Systems Clarifies Coding for Inspire V
The transition is expected to reduce professional fees and potentially impact procedure volume.
Read More
Reaching Remediation Milestone, Philips Respironics Closes US Patient Portal for Recalled CPAPs, BiPAPs
With 99% of actionable sleep therapy registrations remediated globally, the company updates its remediation process and status for ventilators.
Read More